Molecular coupling of DNA methylation and histone methylation

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Clapier CR, Chakravarthy S, Petosa C, Fernandez-Tornero C, Luger K, Muller CW: Structure of the Drosophila nucleosome core particle highlights evolutionary constraints on the H2A-H2B histone dimer. Proteins71,1–7 (2008).
  Medline CASGoogle Scholar
• 2  Strahl BD, Allis CD: The language of covalent histone modifications. Nature403,41–45 (2000).
  Medline CASGoogle Scholar
• 3  Margueron R, Reinberg D: Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet.11,285–296 (2010).
  Medline CASGoogle Scholar
• 4  Probst AV, Dunleavy E, Almouzni G: Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol.10,192–206 (2009).
  Medline CASGoogle Scholar
• 5  Barreto G, Schäfer A, Marhold J et al.: Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature445,671–675 (2007).
  Medline CASGoogle Scholar
• 6  Yuan P, Han J, Guo G et al.: Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev.23,2507–2520 (2009).
  Medline CASGoogle Scholar
• 7  Schaefer CB, Ooi SK, Bestor TH, Bourc’his D: Epigenetic decisions in mammalian germ cells. Science316,398–399 (2007).
  Medline CASGoogle Scholar
• 8  Ehrlich M: DNA methylation and cancer-associated genetic instability. Adv. Exp. Med. Biol.570,363–392 (2005).
  Medline CASGoogle Scholar
• 9  Gronbaek K, Hother C, Jones PA: Epigenetic changes in cancer. APMIS115,1039–1059 (2007).
  MedlineGoogle Scholar
• 10  Kurkjian C, Kummar S, Murgo AJ: DNA methylation: its role in cancer development and therapy. Curr. Probl. Cancer32,187–235 (2008).
  MedlineGoogle Scholar
• 11  Gal-Yam EN, Saito Y, Egger G, Jones PA: Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med.59,267–280 (2008).
  Medline CASGoogle Scholar
• 12  Dobrovic A, Kristensen LS: DNA methylation, epimutations and cancer predisposition. Int. J. Biochem. Cell Biol.41,34–39 (2009).
  Medline CASGoogle Scholar
• 13  McCabe MT, Brandes JC, Vertino PM: Cancer DNA methylation: molecular mechanisms and clinical implications. Clin. Cancer Res.15,3927–3937 (2009).
  Medline CASGoogle Scholar
• 14  Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis31,27–36 (2010).
  Medline CASGoogle Scholar
• 15  Urdinguio RG, Sanchez-Mut JV, Esteller M: Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol.8,1056–1072 (2009).
  Medline CASGoogle Scholar
• 16  Sananbenesi F, Fischer A: The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol. Chem.390,1145–1153 (2009).
  Medline CASGoogle Scholar
• 17  Bernstein BE, Meissner A, Lander ES: The mammalian epigenome. Cell128,669–681 (2007).
  Medline CASGoogle Scholar
• 18  Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature454,766–770 (2008).▪▪ One of the first studies to describe genome-scale DNA methylation patterns at base pair resolution and to compare DNA methylation and histone methylation patterns as they change during cellular differentiation.
  Medline CASGoogle Scholar
• 19  Fan S, Zhang MQ, Zhang X: Histone methylation marks play important roles in predicting the methylation status of CpG islands. Biochem. Biophys. Res. Commun.374,559–564 (2008).
  Medline CASGoogle Scholar
• 20  Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet.10,295–304 (2009).
  Medline CASGoogle Scholar
• 21  Dindot SV, Person R, Strivens M, Garcia R, Beaudet AL: Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regions. Genome Res.19,1374–1383 (2009).
  Medline CASGoogle Scholar
• 22  Laurent L, Wong E, Li G et al.: Dynamic changes in the human methylome during differentiation. Genome Res.20,320–331 (2010).
  Medline CASGoogle Scholar
• 23  Cheng X, Blumenthal RM: Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry49,2999–3008 (2010).
  Medline CASGoogle Scholar
• 24  Tamaru H, Selker EU: A histone H3 methyltransferase controls DNA methylation in Neurospora crassa.Nature414,277–283 (2001).
  Medline CASGoogle Scholar
• 25  Tamaru H, Zhang X, Debra McMillen et al.: Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa.Nat. Genet.34,75–79 (2003).
  Medline CASGoogle Scholar
• 26  Jackson JP, Lindroth AM, Cao X, Jacobsen SE: Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature416,556–560 (2002).
  Medline CASGoogle Scholar
• 27  Lehnertz B, Ueda Y, Derijck AA et al.: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol.13,1192–1200 (2003).
  Medline CASGoogle Scholar
• 28  Matsui T, Leung D, Miyashita H et al.: Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature464,927–931 (2010).▪▪ Suggests a DNA methylation-independent H3K9 methylation pathway involving ESET (also known as SETDB1).
  Medline CASGoogle Scholar
• 29  Nguyen CT, Weisenberger DJ, Velicescu M et al.: Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2´-deoxycytidine. Cancer Res.62,6456–6461 (2002).
  Medline CASGoogle Scholar
• 30  Chen T, Ueda Y, Xie S, Li E: A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem.277,38746–38754 (2002).
  Medline CASGoogle Scholar
• 31  Ooi SK, Qiu C, Bernstein E et al.: DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature448,714–717 (2007).▪▪ Suggests a model whereby absence of H3K4 methylation acts as a signal to recruit DNMT3L and induce DNA methylation by DNMT3a.
  Medline CASGoogle Scholar
• 32  Hu JL, Zhou BO, Zhang RR, Zhang KL, Zhou JQ, Xu GL: The N-terminus of histone H3 is required for de novo DNA methylation in chromatin. Proc. Natl Acad. Sci. USA106,22187–22192 (2009).▪▪ Discusses how the authors tested histone–Dnmt3L–Dnmt3a–DNA interactions in the budding yeast Saccharomyces cerevisiae, and found that induced DNA methylation in yeast preferentially occurs in heterochromatic regions where H3K4 methylation is rare.
  Medline CASGoogle Scholar
• 33  Proffitt JH, Davie JR, Swinton D, Hattman S: 5-methylcytosine is not detectable in Saccharomyces cerevisiae DNA. Mol. Cell Biol.4,985–988 (1984).
  Medline CASGoogle Scholar
• 34  Bulkowska U, Ishikawa T, Kurlandzka A, Trzcinska-Danielewicz J, Derlacz R, Fronk J: Expression of murine DNA methyltransferases Dnmt1 and Dnmt3a in the yeast Saccharomyces cerevisiae.Yeast24,871–882 (2007).
  Medline CASGoogle Scholar
• 35  Wang J, Hevi S, Kurash JK et al.: The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet.41,125–129 (2009).▪ Along with [36], demonstrates that LSD1 and LSD2, two related mammalian H3K4me1/2 demethylases, are essential in maintaining global DNA methylation or establishing maternal DNA genomic imprints, respectively.
  Medline CASGoogle Scholar
• 36  Ciccone DN, Su H, Hevi S et al.: KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature461,415–418 (2009).▪ Along with [35], demonstrates that LSD1 and LSD2, two related mammalian H3K4me1/2 demethylases, are essential in maintaining global DNA methylation or establishing maternal DNA genomic imprints, respectively.
  Medline CASGoogle Scholar
• 37  Kato Y, Kaneda M, Hata K et al.: Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum. Mol. Genet.16,2272–2280 (2007).
  Medline CASGoogle Scholar
• 38  Jeong S, Liang G, Sharma S et al.: Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol. Cell Biol.29,5366–5376 (2009).▪ Revealed that almost all of the cellular DNMT3a and -3b was associated with nucleosomes, primarily associated with methylated short interspersed repetitive nuclear elements and long interspersed repetitive nuclear elements as well as some single-copy methylated CpG islands.
  Medline CASGoogle Scholar
• 39  Zhang Y, Jurkowska R, Soeroes S et al.: Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail. Nucleic Acids Res.38(13),4246–4253 (2010).
  Medline CASGoogle Scholar
• 40  Otani J, Nankumo T, Arita K, Inamoto S, Ariyoshi M, Shirakawa M: Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep.10,1235–1241 (2009).
  Medline CASGoogle Scholar
• 41  Argentaro A, Yang JC, Chapman L et al.: Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. Proc. Natl Acad. Sci. USA104,11939–11944 (2007).
  Medline CASGoogle Scholar
• 42  Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE: UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science317,1760–1764 (2007).
  Medline CASGoogle Scholar
• 43  Sharif J, Muto M, Takebayashi S et al.: The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature450,908–912 (2007).
  Medline CASGoogle Scholar
• 44  Hashimoto H, Horton JR, Zhang X, Cheng X: UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications. Epigenetics4,8–14 (2009).
  Medline CASGoogle Scholar
• 45  Unoki M, Brunet J, Mousli M: Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem. Pharmacol.78,1279–1288 (2009).
  Medline CASGoogle Scholar
• 46  Citterio E, Papait R, Nicassio F et al.: Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol. Cell Biol.24,2526–2535 (2004).
  Medline CASGoogle Scholar
• 47  Karagianni P, Amazit L, Qin J, Wong, J: ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol. Cell Biol.28,705–717 (2008).
  Medline CASGoogle Scholar
• 48  Lan F, Collins RE, De Cegli R et al.: Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature448,718–722 (2007).
  Medline CASGoogle Scholar
• 49  Iwase S, Januma A, Miyamoto K et al.: Characterization of BHC80 in BRAF–HDAC complex, involved in neuron-specific gene repression. Biochem. Biophys. Res. Commun.322,601–608 (2004).
  Medline CASGoogle Scholar
• 50  Org T, Chignola F, Hetényi C et al.: The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep.9,370–376 (2008).
  Medline CASGoogle Scholar
• 51  Chignola F, Gaetani M, Rebane A et al.: The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation. Nucleic Acids Res.37,2951–2961 (2009).
  Medline CASGoogle Scholar
• 52  Helbling Chadwick L, Chadwick BP, Jaye DL, Wade PA: The Mi-2/NuRD complex associates with pericentromeric heterochromatin during S phase in rapidly proliferating lymphoid cells. Chromosoma118,445–457 (2009).
  MedlineGoogle Scholar
• 53  Zegerman P, Canas B, Pappin D, Kouzarides T: Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J. Biol. Chem.277,11621–11624 (2002).
  Medline CASGoogle Scholar
• 54  Nishioka K, Chuikov S, Sarma K et al.: Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev.16,479–489 (2002).
  Medline CASGoogle Scholar
• 55  Musselman CA, Mansfield RE, Garske AL et al.: Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications. Biochem. J.423,179–187 (2009).
  Medline CASGoogle Scholar
• 56  Cosgrove MS, Patel A: Mixed lineage leukemia: a structure-function perspective of the MLL1 protein. FEBS J.277,1832–1842 (2010).
  Medline CASGoogle Scholar
• 57  Ansari KI, Mandal SS: Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J.277,1790–1804 (2010).
  Medline CASGoogle Scholar
• 58  Terranova R, Agherbi H, Boned A, Meresse S, Djabali M: Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of MLL. Proc. Natl Acad. Sci. USA103,6629–6634 (2006).
  Medline CASGoogle Scholar
• 59  Milne TA, Briggs SD, Brock HW et al.: MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell10,1107–1117 (2002).
  Medline CASGoogle Scholar
• 60  Birke M, Schreiner S, Garcia-Cuellar MP, Mahr K, Titgemeyer F, Slany RK: The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res.30,958–965 (2002).
  Medline CASGoogle Scholar
• 61  Ayton PM, Chen EH, Cleary ML: Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell Biol.24,10470–10478 (2004).
  Medline CASGoogle Scholar
• 62  Allen MD, Grummitt CG, Hilcenko C et al.: Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase. EMBO J.25,4503–4512 (2006).
  Medline CASGoogle Scholar
• 63  Cierpicki T, Risner LE, Grembecka J et al.: Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia. Nat. Struct. Mol. Biol.17,62–68 (2010).
  Medline CASGoogle Scholar
• 64  Lee JH, Skalnik DG: CpG-binding protein (CXXC finger protein 1) is a component of the mammalian Set1 histone H3–Lys4 methyltransferase complex, the analogue of the yeast Set1/COMPASS complex. J. Biol. Chem.280,41725–41731 (2005).
  Medline CASGoogle Scholar
• 65  Lee JH, Tate CM, You JS, Skalnik DG: Identification and characterization of the human Set1B histone H3–Lys4 methyltransferase complex. J. Biol. Chem.282,13419–13428 (2007).
  Medline CASGoogle Scholar
• 66  Thomson JP, Skene PJ, Selfridge J et al.: CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature464,1082–1086 (2010).▪▪ Suggests that unmethylated CpGs recruit Cfp1 and the associated methyltransferase Set1 creates new marks of H3K4me3 on the local chromatin.
  Medline CASGoogle Scholar
• 67  Tsukada Y, Fang J, Erdjument-Bromage H et al.: Histone demethylation by a family of JmjC domain-containing proteins. Nature439,811–816 (2006).
  Medline CASGoogle Scholar
• 68  Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ: CpG islands recruit a histone H3 lysine 36 demethylase. Mol. Cell38,179–190 (2010).▪▪ Demonstrates that Jumonji-domain containing histone demethylase, a H3K36me2/1 demethylase, is recruited to the nonmethylated CpG island DNA on a genome-wide scale and that this is dependent on the intrinsic Cys–X–X–Cys domain.
  Medline CASGoogle Scholar
• 69  Jurkowska RZ, Anspach N, Urbanke C et al.: Formation of nucleoprotein filaments by mammalian DNA methyltransferase Dnmt3a in complex with regulator Dnmt3L. Nucleic Acids Res.36,6656–6663 (2008).
  Medline CASGoogle Scholar
• 70  Pradhan M, Esteve PO, Chin HG, Samaranayke M, Kim GD, Pradhan S: CXXC domain of human DNMT1 is essential for enzymatic activity. Biochemistry47,10000–10009 (2008).
  Medline CASGoogle Scholar
• 71  Jorgensen HF, Ben-Porath I, Bird AP: Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol. Cell Biol.24,3387–3395 (2004).
  Medline CASGoogle Scholar
• 72  Tahiliani M, Koh KP, Shen Y et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science324,930–935 (2009).▪▪ Among the first studies to demonstrate that 5-methylcytosine can be converted to hydroxymethylcytosine and explain the relevance of this modified base in the human genome.
  Medline CASGoogle Scholar
• 73  Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y: LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res.62,4075–4080 (2002).
  Medline CASGoogle Scholar
• 74  Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR: TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia17,637–641 (2003).
  Medline CASGoogle Scholar
• 75  Dhasarathy A, Wade PA: The MBD protein family-reading an epigenetic mark? Mutat. Res.647,39–43 (2008).
  Medline CASGoogle Scholar
• 76  Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A: The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature401,301–304 (1999).
  Medline CASGoogle Scholar
• 77  Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR: DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell135,1201–1212 (2008).▪ Suggests that in zebrafish, methyl-CpG-binding domain 4 (containing both a N-terminal methyl-CpG-binding domain and a C-terminal thymine glycosylase domain) is involved in demethylating DNA.
  Medline CASGoogle Scholar
• 78  Popp C, Dean W, Feng S et al.: Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature463,1101–1105 (2010).▪▪ Together with [79], demonstrates that the cytidine deaminase AID has a role in DNA demethylation.
  Medline CASGoogle Scholar
• 79  Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM: Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature463,1042–1047 (2010).▪▪ Together with [78], demonstrates that the cytidine deaminase AID has a role in DNA demethylation.
  Medline CASGoogle Scholar
• 80  Kim MS, Kondo T, Takada I et al.: DNA demethylation in hormone-induced transcriptional derepression. Nature461,1007–1012 (2009).
  Medline CASGoogle Scholar
• 81  Sarraf SA, Stancheva I: Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol. Cell15,595–605 (2004).
  Medline CASGoogle Scholar
• 82  Lyst MJ, Nan X, Stancheva I: Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBO J.25,5317–5328 (2006).
  Medline CASGoogle Scholar
• 83  Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd: SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev.16,919–932 (2002).
  Medline CASGoogle Scholar
• 84  Rowe HM, Jakobsson J, Mesnard D et al.: KAP1 controls endogenous retroviruses in embryonic stem cells. Nature463,237–240 (2010).
  Medline CASGoogle Scholar
• 85  Fujita N, Watanabe S, Ichimura T et al.: Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J. Biol. Chem.278,24132–24138 (2003).
  Medline CASGoogle Scholar
• 86  Ohki I, Shimotake N, Fujita N et al.: Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell105,487–497 (2001).
  Medline CASGoogle Scholar
• 87  Ho KL, McNae IW, Schmiedeberg L, Klose RJ, Bird AP, Walkinshaw MD: MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell29,525–531 (2008).
  Medline CASGoogle Scholar
• 88  McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB: Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res.66,3541–3549 (2006).
  Medline CASGoogle Scholar
• 89  Egger G, Aparicio AM, Escobar SG, Jones PA: Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2’-deoxycytidine treatment. Cancer Res.67,346–353 (2007).
  Medline CASGoogle Scholar
• 90  Collins R, Cheng, X: A case study in cross-talk: the histone lysine methyltransferases G9a and GLP. Nucleic Acids Res.38,3503–3511 (2010).
  Medline CASGoogle Scholar
• 91  Clouaire T, de Las Heras JI, Merusi C, Stancheva I: Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res.38(14),4620–4634 (2010).
  Medline CASGoogle Scholar
• 92  Walker JR, Avvakumov GV, Xue S et al.: Crystal structure of the tandem Tudor domains of the E3 ubiquitin-protein ligase UHRF1 in complex with trimethylated histone H3-K9 peptide. doi:10.2210/pdb3db3/pdb. (2008) (Epub ahead of print).
  Google Scholar
• 93  Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H: The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res.38,1796–1804 (2009).
  MedlineGoogle Scholar
• 94  Hashimoto H, Horton JR, Zhang X, Bostick M, Jacobsen SE, Cheng X: The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature455,826–829 (2008).
  Medline CASGoogle Scholar
• 95  Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M: Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature455,818–821 (2008).
  Medline CASGoogle Scholar
• 96  Avvakumov GV, Walker JR, Xue S et al.: Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature455,822–825 (2008).
  Medline CASGoogle Scholar
• 97  Tubbs JL, Latypov V, Kanugula S et al.: Flipping of alkylated DNA damage bridges base and nucleotide excision repair. Nature459,808–813 (2009).
  Medline CASGoogle Scholar
• 98  Kim JK, Esteve PO, Jacobsen SE, Pradhan S: UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res.37,493–505 (2009).
  Medline CASGoogle Scholar
• 99  Achour M, Fuhrmann G, Alhosin M et al.: UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem. Biophys. Res. Commun.390,523–528 (2009).
  Medline CASGoogle Scholar
• 100  Xu M, Long C, Chen X, Huang C, Chen S, Zhu B: Partitioning of histone H3-H4 tetramers during DNA replication-dependent chromatin assembly. Science328,94–98 (2010).▪▪ Demonstrates that histone H3.1–H4 tetramers remain intact and are partitioned evenly during DNA replication-dependent chromatin assembly.
  Medline CASGoogle Scholar
• 101  Collins RE, Northrop JP, Horton JR et al.: The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat. Struct. Mol. Biol.15,245–250 (2008).
  Medline CASGoogle Scholar
• 102  Grewal SI, Jia S: Heterochromatin revisited. Nat. Rev. Genet.8,35–46 (2007).
  Medline CASGoogle Scholar
• 103  Zhang K, Mosch K, Fischle W, Grewal SI: Roles of the Clr4 methyltransferase complex in nucleation, spreading and maintenance of heterochromatin. Nat. Struct. Mol. Biol.15,381–388 (2008).
  Medline CASGoogle Scholar
• 104  Peisajovich SG, Garbarino JE, Wei P, Lim WA: Rapid diversification of cell signaling phenotypes by modular domain recombination. Science328,368–372 (2010).
  Medline CASGoogle Scholar